Andrew Blauvelt
Dermatology · Portland, ORNPI 1932115425
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (52.1%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 19.9%. Among dermatology clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,152 payments — averaging $1562.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$359K
- Lilly USA, LLC$327K
- UCB, Inc.$235K
- E.r. Squibb & Sons, L.L.C.$161K
- Eli Lilly$147K
- Pfizer$91K
- plus $480K from 29 others
Across 1,887 payments — averaging $9142.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$6.2M
- UCB SA$2.8M
- Eli Lilly$2.3M
- Incyte Corporation$1.3M
- Pfizer$961K
- Amgen$950K
- plus $2.8M from 16 others
What the payments were for
- Consulting fees$731,17241%
- Speaking & faculty fees$937,22452%
- Travel & lodging$109,5566%
- Food & beverage$14,1991%
- Education$8,2210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 232 | $358,664 |
| Lilly USA, LLC | 221 | $326,714 |
| UCB, Inc. | 177 | $235,272 |
| E.r. Squibb & Sons, L.L.C. | 82 | $160,531 |
| Eli Lilly | 78 | $147,489 |
| Pfizer | 29 | $91,399 |
| Sanofi | 45 | $76,781 |
| Regeneron Healthcare Solutions, Inc. | 60 | $65,118 |
| LEO Pharma Inc. | 25 | $52,456 |
| LEO Pharma AS | 19 | $36,911 |
| Dermira, Inc. | 33 | $30,213 |
| Sanofi-aventis U.S. LLC | 5 | $29,263 |
| Janssen Scientific Affairs, LLC | 19 | $27,260 |
| UCB SA | 12 | $25,006 |
| Incyte Corporation | 21 | $21,628 |
| Amgen | 18 | $15,863 |
| Novartis | 19 | $14,607 |
| Sun Pharmaceutical Industries Inc. | 10 | $13,667 |
| Janssen Global Services, LLC | 7 | $12,782 |
| Almirall LLC | 6 | $12,599 |
| GSK | 3 | $8,600 |
| Merck | 1 | $8,100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $4,802 |
| Johnson & Johnson | 7 | $3,925 |
| EMD Serono, Inc. | 2 | $3,900 |
| Boehringer Ingelheim International GmbH | 1 | $3,240 |
| EMD Serono Research & Development Institute, Inc. | 3 | $3,200 |
| CTI Biopharma Corp. | 1 | $2,400 |
| Celltrion, Inc. | 1 | $2,400 |
| UCB GmbH | 2 | $1,750 |
| Janssen Research & Development, LLC | 1 | $1,500 |
| Samsung Bioepis Co., Ltd. | 1 | $1,000 |
| Boehringer Ingelheim | 1 | $720 |
| Sanofi US Services Inc. | 2 | $454 |
| Arcutis Biotherapeutics, Inc. | 1 | $158 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,800,372 in reported general payments places this provider in the 95th percentile of 175 dermatology providers in Oregon.
Other dermatology in Portland
- Benjamin EhstPortland$1.5M
- Jason HawkesPortland$1.5M
- Eric SimpsonPortland$1.4M
- Alex Ortega LoayzaPortland$122K
- Omar QutubPortland$107K
- Paul HaunPortland$85K
- Kathryn SchwarzenbergerPortland$34K
- Jon HanifinPortland$25K
- Phoebe RichPortland$17K
- Tracy FunkPortland$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.